Charles D Gill Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles D Gill.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles D Gill. Charles D Gill is Executive VP & General Counsel in UNITED TECHNOLOGIES CORP /DE/ ($UTX) and Senior VP and General Counsel in UNITED TECHNOLOGIES CORP /DE/ ($UTX).
Latest Insider Trading Transactions of Charles D Gill
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 07 2020 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 0.00 | 5,884 | 0 | 0 | |
| Jan 07 2020 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Payment of Exercise | F | 153.35 | 1,708 | 261,922 | 37,440 | 39.1 K to 37.4 K (-4.36 %) |
| Jan 07 2020 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 0.00 | 5,884 | 0 | 39,148 | 33.3 K to 39.1 K (+17.69 %) |
| Nov 15 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 141.17 | 3,694 | 521,489 | 33,264 | 37 K to 33.3 K (-10.00 %) |
| Oct 25 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 84.00 | 18,250 | 1,533,000 | 54,750 | |
| Oct 25 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 142.17 | 10,782 | 1,532,877 | 36,958 | 47.7 K to 37 K (-22.58 %) |
| Oct 25 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 142.19 | 7,468 | 1,061,888 | 47,740 | 55.2 K to 47.7 K (-13.53 %) |
| Oct 25 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 84.00 | 18,250 | 1,533,000 | 55,208 | 37 K to 55.2 K (+49.38 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 74.66 | 75,500 | 5,636,830 | 0 | |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 135.00 | 14,102 | 1,903,770 | 36,958 | 51.1 K to 37 K (-27.62 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 135.04 | 13,821 | 1,866,388 | 51,060 | 64.9 K to 51.1 K (-21.30 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 135.11 | 13,814 | 1,866,410 | 64,881 | 78.7 K to 64.9 K (-17.55 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 134.96 | 11,398 | 1,538,234 | 78,695 | 90.1 K to 78.7 K (-12.65 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 135.08 | 11,186 | 1,511,013 | 90,093 | 101.3 K to 90.1 K (-11.04 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 135.09 | 11,179 | 1,510,121 | 101,279 | 112.5 K to 101.3 K (-9.94 %) |
| Sep 13 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 74.66 | 75,500 | 5,636,830 | 112,458 | 37 K to 112.5 K (+204.29 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 78.99 | 66,500 | 5,252,835 | 0 | |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 131.48 | 13,517 | 1,777,215 | 36,958 | 50.5 K to 37 K (-26.78 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 131.44 | 13,221 | 1,737,768 | 50,475 | 63.7 K to 50.5 K (-20.76 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 131.45 | 13,220 | 1,737,769 | 63,696 | 76.9 K to 63.7 K (-17.19 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 131.43 | 8,983 | 1,180,636 | 76,916 | 85.9 K to 76.9 K (-10.46 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 131.43 | 8,780 | 1,153,955 | 85,899 | 94.7 K to 85.9 K (-9.27 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 131.41 | 8,779 | 1,153,648 | 94,679 | 103.5 K to 94.7 K (-8.49 %) |
| Sep 06 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 78.99 | 66,500 | 5,252,835 | 103,458 | 37 K to 103.5 K (+179.93 %) |
| Feb 07 2019 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | A | 120.77 | 84,000 | 10,144,680 | 84,000 | |
| Dec 06 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Grant | A | 0.00 | 22 | 0 | 25,051 | 25 K to 25.1 K (+0.09 %) |
| Jul 27 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 71.63 | 30,000 | 2,148,900 | 30,500 | |
| Jul 27 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 136.48 | 15,745 | 2,148,878 | 25,029 | 40.8 K to 25 K (-38.62 %) |
| Jul 27 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 136.43 | 14,255 | 1,944,781 | 40,774 | 55 K to 40.8 K (-25.90 %) |
| Jul 27 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 71.63 | 30,000 | 2,148,900 | 55,029 | 25 K to 55 K (+119.86 %) |
| May 24 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 128.48 | 9,700 | 1,246,204 | 25,029 | 34.7 K to 25 K (-27.93 %) |
| Jan 04 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | A | 128.16 | 43,500 | 5,574,960 | 43,500 | |
| Jan 04 2018 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | A | 0.00 | 5,300 | 0 | 5,300 | |
| Feb 21 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 54.95 | 74,500 | 4,093,775 | 0 | |
| Feb 21 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 112.02 | 37,975 | 4,253,766 | 31,778 | 69.8 K to 31.8 K (-54.44 %) |
| Feb 21 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 112.08 | 36,525 | 4,093,722 | 69,753 | 106.3 K to 69.8 K (-34.37 %) |
| Feb 21 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 54.95 | 74,500 | 4,093,775 | 106,278 | 31.8 K to 106.3 K (+234.44 %) |
| Feb 08 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 70.81 | 45,000 | 3,186,450 | 0 | |
| Feb 08 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 111.13 | 19,115 | 2,124,250 | 31,778 | 50.9 K to 31.8 K (-37.56 %) |
| Feb 08 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 111.10 | 16,329 | 1,814,163 | 50,893 | 67.2 K to 50.9 K (-24.29 %) |
| Feb 08 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 111.15 | 9,556 | 1,062,149 | 67,222 | 76.8 K to 67.2 K (-12.45 %) |
| Feb 08 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 70.81 | 45,000 | 3,186,450 | 76,778 | 31.8 K to 76.8 K (+141.61 %) |
| Jan 05 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | A | 110.83 | 41,500 | 4,599,445 | 41,500 | |
| Jan 05 2017 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
| Dec 09 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 70.81 | 45,000 | 3,186,450 | 45,000 | |
| Dec 09 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 109.11 | 29,204 | 3,186,448 | 31,778 | 61 K to 31.8 K (-47.89 %) |
| Dec 09 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 108.98 | 15,796 | 1,721,415 | 60,982 | 76.8 K to 61 K (-20.57 %) |
| Dec 09 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 70.81 | 45,000 | 3,186,450 | 76,778 | 31.8 K to 76.8 K (+141.61 %) |
| Aug 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 75.21 | 20,000 | 1,504,200 | 0 | |
| Aug 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 109.01 | 13,798 | 1,504,120 | 31,778 | 45.6 K to 31.8 K (-30.27 %) |
| Aug 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 109.00 | 6,202 | 676,032 | 45,576 | 51.8 K to 45.6 K (-11.98 %) |
| Aug 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 75.21 | 20,000 | 1,504,200 | 51,778 | 31.8 K to 51.8 K (+62.94 %) |
| Jul 29 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 75.21 | 23,500 | 1,767,435 | 20,000 | |
| Jul 29 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 108.06 | 16,356 | 1,767,429 | 31,778 | 48.1 K to 31.8 K (-33.98 %) |
| Jul 29 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 108.05 | 7,144 | 771,910 | 48,134 | 55.3 K to 48.1 K (-12.92 %) |
| Jul 29 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 75.21 | 23,500 | 1,767,435 | 55,278 | 31.8 K to 55.3 K (+73.95 %) |
| Jun 10 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Option Exercise | M | 62.81 | 23,300 | 1,463,473 | 0 | |
| Jun 10 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | D | 102.04 | 14,342 | 1,463,458 | 31,778 | 46.1 K to 31.8 K (-31.10 %) |
| Jun 10 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Sell | S | 102.04 | 8,958 | 914,098 | 46,120 | 55.1 K to 46.1 K (-16.26 %) |
| Jun 10 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Buy | M | 62.81 | 23,300 | 1,463,473 | 55,078 | 31.8 K to 55.1 K (+73.32 %) |
| Feb 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Payment of Exercise | F | 86.96 | 2,712 | 235,836 | 31,778 | 34.5 K to 31.8 K (-7.86 %) |
| Feb 12 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Executive VP & Gene ... | Grant | A | 86.96 | 7,876 | 684,897 | 34,490 | 26.6 K to 34.5 K (+29.59 %) |
| Jan 06 2016 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Option Exercise | A | 95.57 | 86,000 | 8,219,020 | 86,000 | |
| Oct 28 2015 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Sell | S | 100.88 | 2,889 | 291,442 | 26,614 | 29.5 K to 26.6 K (-9.79 %) |
| Oct 28 2015 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Sell | S | 100.86 | 500 | 50,432 | 29,503 | 30 K to 29.5 K (-1.67 %) |
| Oct 28 2015 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Sell | S | 100.88 | 400 | 40,352 | 30,003 | 30.4 K to 30 K (-1.32 %) |
| Oct 28 2015 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Sell | S | 100.86 | 211 | 21,281 | 30,403 | 30.6 K to 30.4 K (-0.69 %) |
| Oct 03 2007 | UTX | UNITED TECHNOLOGIE ... | Gill Charles D | Senior VP and Gener ... | Option Exercise | A | 0.00 | 8,530 | 0 | 8,530 |
Page: 1